期刊文献+

氯吡格雷抵抗相关因素的研究进展 被引量:21

Progress in Research to Related Factors for Clopidogrel Resistance
下载PDF
导出
摘要 临床上部分冠状动脉性心脏病患者未从氯吡格雷抗血小板治疗中获益,这就是氯吡格雷抵抗现象。氯吡格雷抵抗反映氯吡格雷抗血小板治疗失败。研究表明,氯吡格雷抵抗可能与血栓事件复发密切相关。它可能受多个因素影响,主要分为内源性和外源性两方面。现就氯吡格雷抵抗的检测方法、影响因素及临床对策进行了详细综述。 Clinically,many patients with coronary artery disease cannot benefit from clopidogrel medication,as a result of clopidogrel resistance.Clopidogrel resistance describes the failure of clopidogrel to achieve its antiplatelet aggregation effect,or a clinical entity with potentially severe consequences such as recurrent artery thrombosis.This article reviews the different methods for monitoring platelet inhibition with clopidogrel,as well as factors related to clopidogrel resistance.
出处 《心血管病学进展》 CAS 2009年第6期991-994,共4页 Advances in Cardiovascular Diseases
关键词 氯吡格雷 氯吡格雷抵抗 血小板聚集 clopidogrel clopidogrel resistance platelet aggregation
  • 相关文献

参考文献10

  • 1Gergely F,,Elod P.Clopidogrel resistance:a diagnostic challenge:reply[].International Journal of Cardiology.2007
  • 2Malinin A,Pokov A,Swaim L,et al.Validation of a VerifyNow-P2Y12 cartridgefor monitoring platelet inhibition with clopidogrel[].Methods Find Exp ClinPharmacol.2006
  • 3Velik-Salchner C,Maier S,Innerhofer P,et al.Point-of-care whole blood imped-ance aggregometry versus classical light transmission aggregometry for detectingaspirin and clopidogrel:the results of a pilot study[].Anesthesia and Analgesia.2008
  • 4Paniccia R,Antonucci E,Gori AM,et al.Different methodologies for evaluatingthe effect of clopidogrel on platelet function in high-risk coronary artery diseasepatients[].Journal of Thrombosis and Haemostasis.2007
  • 5Bal Dit Sollier C,Berge N,Boval B,et al.Functional variability of platelet re-sponse to clopidogrel correlates with P2Y(12)receptor occupancy[].Thrombosis and Haemostasis.2009
  • 6Beres BJ,Toth-Zsamboki E,Vargova K,et al.Analysis of platelet alpha2-adren-ergic receptor activity in stable coronary artery disease patients on dual anti-platelet therapy[].Thrombosis and Haemostasis.2008
  • 7Lau W C,Gurbel P A,Watkins P B,et al.Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance[].Circulation.2004
  • 8Gurbel PA,Bliden KP,Hiatt BL,et al.Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity[].Circulation.2003
  • 9Soffer D,Moussa I,Harjai K J,et al.Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina[].Catheterization and Cardiovascular Interventions.2003
  • 10Lepantalo A,Virtanen KS,Heikkila J,et al.Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions[].European Heart Journal.2004

同被引文献246

引证文献21

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部